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ANNEXIN A5:  
SHIFTING FROM MOLECULAR IMAGING TOOL TO 
THERAPEUTIC AGENT IN CARDIOVASCULAR DISEASES 
 
 1. Phosphatidylserine externalization is one of the most prominent and ubiquitous 
fingerprints of cells in diseased tissues and, therefore, an attractive target for 
molecular imaging and translation into clinical applications. (this thesis) 
 
 2. Circulating anxA5 levels predict mortality of heart failure patients. (this thesis) 
 
 3. The anxA5-/- mouse is the first preclinical model to investigate diastolic heart 
failure. (this thesis) 
 
 4. RGD-anxA5 opens a novel portal to diagnose and treat diseases. (this thesis) 
 
 5. Studying the biology of annexins compares to sailing unchartered seas. 
 
 6. Annexin A1 and annexin A5 are the most important annexins in modulating the 
host response in immune and vascular diseases. 
 
 7. "While I thought that I was learning how to live, I have been learning how to die" 
(Leonardo da Vinci) 
 
 8. micro - RNA’s zijn hoofdrolspelers in macro – processen. 
 
 9. Wacht niet tot later, want als later iets eerder komt, ben je te laat. 
 
 10. Je grootste fouten zijn fouten die je niet durft te maken.  
 
 	  
